RG6733
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 24, 2026
A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
(clinicaltrials.gov)
- P1 | N=160 | Recruiting | Sponsor: Genentech, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1